US4851433A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic agents containing tamoxifen and salts thereof
Assignee: Imperial Chemical Industries Ltd
•
Filing: 1987-02-17
•
Granted: 1989-07-25
•
Expires: 2007-02-17
Abstract
Abstract The invention concerns a new therapeutic agent for use in treating psoriasis, new compositions of the therapeutic agent for topical administration and a new method of treating psoriasis.
Inventors
- 👤 Hans A. Kraus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 06:37
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/205; A61K31/13; A61K31/135; A61P; A61P17/00; A61P35/00
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
35 words
A method for the treatment of psoriasis in a warm-blooded animal requiring such treatment which comprises administering to said animal an effective amount of therapeutic agent selected from tamoxifen and the pharmaceutically acceptable salts thereof.
Claim 2
Independent Claim
35 words
A method for the treatment of psoriasis in a warm-blooded animal requiring such treatment which comprises administering to said animal an effective amount of therapeutic agent selected from tamoxifen and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
13 words
The method of claim 1 wherein the pharmaceutically acceptable salts are water-soluble salts.
Claim 4
Dependent Claim
15 words
The method of claim 1 wherein the therapeutic agent is the D-gluconate salt of tamoxifen.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-07-24 | 1993-01-23 | 1993-07-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-07-24 | 1997-01-23 | 1997-07-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-07-24 | 2001-01-23 | 2001-07-25 | $7700.00 | Window Closed / Lapsed |